黄连素联合利福定灌肠治疗小儿细菌性痢疾的疗效观察  

Clinical observation of berberine and rifandin enema on the treatment of infantile bacillary dysentery

作　　者：洪美珍[1] 

机构地区：[1]南昌大学抚州医学分院,344000

出　　处：《中国医学创新》2010年第4期18-18,共1页Medical Innovation of China

摘　　要：目的观察黄连素联合利福定保留灌肠治疗小儿细菌性痢疾的疗效。方法将98例患儿分为观察组49例和对照组49例,观察组用黄连素、利福定保留灌肠。对照组用呋喃唑酮、庆大霉素保留灌肠.结果观察组显效36例,有效11例,无效2例,有效率为95.9%.对照组显效20例,有效19例,无效10例,有效率为79.6%。结论黄连素联合利福定保留灌肠能缩短病程,疗效佳,且未发现不良反应。Objective To observe the berberine, Rifandin retention enema efficacy of treatment of children with bacillary dysentery. Methods 98 cases were divided into 49 cases of the observation group and control group 49 cases, the observation group with berberine, Rifandin retention enema. The control group with furazolidone, gentamicin retention enema. Results The observation group of 36 cases markedly effective in 11 cases, 2 cases, efficieney of 95.9%. Control group, 20 cases markedly effective in 19 cases, ineffective in 10 cases, efficiency of 79.6%. Conclusion Brberine, Rifandin retention enema can shorten the course of the disease, efficacy good, and didn＇t find adverse reactions.

关 键 词：黄连素 利福定 保留灌肠 小儿细菌性痢疾 

分 类 号：R725.1[医药卫生—儿科]